Skip to main content

Table 8 Absolute Serum Chemistry Measures in the Modified Intention to Treat Population

From: Safety and efficacy of an olive oil-based triple-chamber bag for parenteral nutrition: a prospective, randomized, multi-center clinical trial in China

Serum Chemistry Measure

OLIVE

SOYBEAN

OLIVE vs SOYBEAN

 

Visit

N

Mean ± SD

N

Mean ± SD

LS Mean ± SE (95 % CI)

P-value

Alanine aminotransferase, U/L

Baseline

212

41.4 ± 87.15

216

73.3 ± 197.14

  
 

Day 5

79

31.0 ± 27.86

85

29.2 ± 55.41

21.3 ± 6.89 (7.7, 34.9)

0.002

 

EOT/Day 14

201

48.8 ± 61.23

196

38.5 ± 38.70

42.5 ± 15.24 (12.5, 72.5)

0.006

Alkaline phosphatase, U/L

Baseline

210

72.5 ± 46.87

212

71.7 ± 35.65

  
 

Day 5

79

87.7 ± 58.27

85

74.7 ± 40.41

18.8 ± 5.65 (7.7, 30.0)

0.001

 

EOT/Day 14

201

123 ± 96.24

196

106.9 ± 70.89

11.6 ± 7.72 (−3.6, 26.8)

0.133

Aspartate aminotransferase, U/L

Baseline

210

52.8 ± 117.38

212

72.3 ± 191.38

  
 

Day 5

79

31.9 ± 19.27

85

22.6 ± 15.82

22.4 ± 8.87 (4.9, 40.0)

0.12

 

EOT/Day 14

201

35.8 ± 39.42

196

30.6 ± 35.13

25.5 ± 17.25 (−8.5, 59.4)

0.141

γ-Glutamyltransferase, U/L

Baseline

210

39.2 ± 74.63

212

42.7 ± 70.32

  
 

Day 5

79

100.5 ± 136.62

85

68.9 ± 71.69

34.9 ± 11.96 (11.3, 58.5)

0.004

 

EOT/Day 14

201

139.2 ± 165.89

196

118.1 ± 140.65

12.4 ± 13.45 (−14.1, 38.8)

0.358

Total bilirubin, μmol/L

Baseline

212

18.00 ± 15.98

216

16.12 ± 10.69

  
 

Day 5

79

13.21 ± 9.76

85

11.86 ± 9.56

−0.39 ± 1.50 (−3.35, 2.56)

0.793

 

EOT/Day 14

201

12.86 ± 9.34

196

13.87 ± 18.94

−2.97 ± 1.42 (−5.76, −0.19)

0.36

Blood urea nitrogen, mmol/L

Baseline

212

3.63 ± 2.07

216

3.88 ± 1.91

  
 

Day 5

85

4.21 ± 2.51

92

4.35 ± 2.71

0.51 ± 0.24 (0.03, 0.99)

0.039

 

EOT/Day 14

200

5.23 ± 2.47

195

4.93 ± 2.27

0.38 ± 0.21 (−0.03, 0.79)

0.072

Creatinine, μmol/L

Baseline

212

67.8 ± 23.6

218

67.4 ± 21.1

  
 

Day 7

110

62.0 ± 15.8

112

60.2 ± 17.4

−2.3 ± 2.7 (–7.5, 3.0)

0.40

 

EOT/Day 14

200

62.6 ± 16.5

195

62.2 ± 16.7

−0.7 ± 1.7 (-4.1, 2.7)

0.69

Chloride, mmol/L

Baseline

212

104.4 ± 4.33

216

103.7 ± 4.39

  
 

Day 5

85

101.4 ± 3.55

93

102.4 ± 4.53

−1.6 ± 0.73 (−3.1, −0.2)

0.027

 

EOT/Day 14

200

101.0 ± 3.55

194

101.8 ± 5.03

−1.3 ± 0.59 (−2.5, −0.1)

0.030

Phosphorus, mmol/L

Baseline

155

1.07 ± 0.26

162

1.15 ± 0.79

  
 

Day 5

83

1.21 ± 0.47

89

0.98 ± 0.45

0.25 ± 0.09 (0.09, 0.42)

0.003

 

EOT/Day 14

183

1.26 ± 0.21

176

1.20 ± 0.32

0.17 ± 0.08 (0.00, 0.34)

0.044

Potassium, mmol/L

Baseline

212

4.58 ± 9.07

216

3.98 ± 0.47

  
 

Day 5

85

4.35 ± 0.57

93

3.95 ± 0.53

0.43 ± 0.10 (0.23, 0.63)

<0.001

 

EOT/Day 14

201

4.97 ± 9.16

194

4.06 ± 0.53

0.28 ± 0.06 (0.15, 0.40)

<0.001

Total cholesterol, mmol/L

Baseline

206

3.52 ± 0.95

210

3.60 ± 0.89

  
 

Day 5

77

3.48 ± 0.96

84

7.60 ± 38.15

−4.35 (−13.47, 4.77)

0.348

 

EOT/Day 14

196

3.76 ± 0.90

188

3.6 ± 0.94

0.20 (0.02, 0.39)

0.029

Triglycerides, mmol/L

Baseline

206

0.89 ± 0.53

211

0.91 ± 0.58

  
 

Day 5

77

1.89 ± 0.95

85

1.51 ± 0.68

0.41 (0.19, 0.63)

<0.001

 

EOT/Day 14

200

1.72 ± 0.88

193

1.50 ± 0.67

0.25 (0.09, 0.40)

0.002

  1. Abbreviations: CI confidence interval, EOT end of treatment, LS least squares, SD standard deviation, SE standard error